查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949629

AI for MRI 市場 - 全球產業規模、佔有率、趨勢、機會及預測（按臨床應用、產品類型、技術、部署類型、最終用途、地區和競爭格局分類，2021-2031 年）

AI in MRI Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Clinical Application, By Offering Type, By Technology, By Deployment Type, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球用於 MRI 的 AI 市場預計將從 2025 年的 17.3 億美元成長到 2031 年的 45.8 億美元，複合年成長率為 17.62%。

該領域涉及將機器學習和深度學習技術整合到磁振造影(MRI) 工作流程中，以實現影像重建的自動化並輔助診斷解讀。推動這項發展的關鍵因素包括：迫切需要縮短掃描時間以提高患者就診效率，以及由於病例數量不斷增加而需要減輕放射科醫師的工作量。歐洲放射學會 (ESR) 2024 年的數據顯示，48% 的受訪會員表示目前在其臨床實踐中使用人工智慧工具，這印證了這項技術變革。

市場概覽
預測期 2027-2031
市場規模：2025年 17.3億美元
市場規模：2031年 45.8億美元
複合年成長率：2026-2031年 17.62%
成長最快的細分市場 深度學習
最大的市場 北美洲

然而，市場成長的一大障礙是實施所需的大量資本投入。取得軟體授權和升級IT基礎設施的高成本構成了一道重要的進入門檻，尤其對於發展中地區的中小型獨立診所和醫療系統而言更是如此。因此，儘管這些工具能夠顯著提高營運效率，但預算限制往往迫使醫療機構推遲採用。

市場促進因素

放射科醫師嚴重短缺和診斷影像工作量的快速成長是推動人工智慧在磁振造影（MRI）領域應用的關鍵因素。醫療系統面臨診斷掃描需求與解讀所需人才之間日益擴大的差距，因此亟需自動化解決方案來防止醫護人員過度勞累和延遲診斷。勞動力數據也印證了這種不平衡。根據英國皇家放射學院於2024年6月發布的《2023年臨床放射科勞動力調查報告》，英國英國放射科醫生人數在2023年將成長6%，但對CT和MRI閱片的需求將成長11%，這將給現有醫護人員帶來更大的壓力。

此外，深度學習技術的進步增強了影像重建能力，直接提高了營運效率和患者吞吐量，從而推動了市場擴張。現代人工智慧演算法能夠從欠採樣原始資料中產生高解析度影像，顯著縮短患者在掃描儀中的停留時間，同時又不影響診斷品質。 2024年12月，GE醫療發布了「Sonic DL for 3D」深度學習技術，將MRI掃描時間縮短了高達86%，充分展現了這項能力。這種效率提升潛力吸引了大量資金，Ezra公司於2024年2月成功資金籌措2,100萬美元，以加速其人工智慧驅動的MRI服務的擴張。

市場挑戰

實施所需的大量資本投入極大地限制了全球人工智慧在磁振造影（MRI）領域的市場成長。部署這些解決方案涉及高昂的軟體授權費用和IT基礎設施升級成本，以適應資料密集型工作流程。這些財務要求構成了巨大的進入門檻，尤其對於預算有限的小規模獨立診所和發展中地區的醫療系統而言更是如此。因此，儘管這些技術具有提升營運效率的潛力，但醫療機構往往會延後採用，阻礙了市場充分發揮其潛力。

近期統計數據印證了這些經濟限制對產業的影響。根據歐洲放射學會 (ESR) 2024 年的數據，49.5% 的受訪會員表示，成本或預算不足是其臨床環境中採用人工智慧的主要障礙。這表明，資金障礙是放射科遲遲不願整合這些工具的主要原因。如果沒有足夠的資金來支付初始成本，相當一部分市場將無法利用人工智慧技術，這將直接限制整個市場的擴張。

市場趨勢

將生成式人工智慧 (AI) 整合到放射學報告中正迅速普及，成為解決診斷工作流程中繁重行政負擔的關鍵方案。這一趨勢超越了傳統的影像分析，利用大規模語言模型，根據影像學觀察和放射科醫生的口述自動創建、自訂和建立臨床報告，從而減少文件記錄時間和放射科醫生的疲勞。 2025 年 1 月，Rad AI 完成 6,000 萬美元的 C 輪資金籌措，加速其生成式 AI 報告平台在大型醫療系統中的應用，這有力地證明了該技術的商業性可行性。

同時，廠商中立的AI應用商店的興起正在改變醫療機構部署和運作人工智慧工具的方式。醫院不再需要管理與各個開發商簽訂的零散契約，而是擴大採用整合平台，以便集中管理來自多個供應商的各種演算法。這項整合策略在2025年12月舉行的RSNA 2025大會上得到了重點展示。當時，DeepHealth發布了AI Studio，編配平台，整合了來自75多家供應商的140多種AI演算法，並簡化了臨床部署和管治。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球MRI人工智慧市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依臨床應用（肌肉骨骼、結腸、前列腺、肝臟、心血管、神經系統、肺部、乳房、其他）
    • 依供應類型（硬體、軟體、服務）
    • 按技術（深度學習、機器學習、電腦視覺、自然語言處理、語音辨識、查詢方法等）
    • 依部署類型（本機部署、雲端部署）
    • 依最終使用者（醫院、診所、實驗室等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美MRI人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲人工智慧在磁振造影市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區MRI人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲MRI人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美MRI人工智慧市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球人工智慧在磁振造影市場的應用：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Digital Diagnostics Inc.
  • Tempus AI, Inc.
  • Advanced Micro Devices, Inc.
  • HeartFlow, Inc.
  • Enlitic, Inc.
  • Viz.ai, Inc.
  • EchoNous Inc.
  • HeartVista Inc.
  • Exo Imaging, Inc.
  • Nano-X Imaging Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27561

The Global AI in MRI Market is projected to expand from USD 1.73 Billion in 2025 to USD 4.58 Billion by 2031, registering a CAGR of 17.62%. This sector encompasses machine learning and deep learning technologies integrated into magnetic resonance imaging workflows to automate image reconstruction and support diagnostic interpretation. Key drivers for this growth include the urgent need to shorten scan times for better patient throughput and the demand to alleviate radiologist burnout amidst rising caseloads. Evidence of this technological shift is found in recent data from the European Society of Radiology, which reported in 2024 that 48% of its surveyed members are currently utilizing AI tools in their clinical practice.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.73 Billion
Market Size 2031USD 4.58 Billion
CAGR 2026-203117.62%
Fastest Growing SegmentDeep Learning
Largest MarketNorth America

However, a major obstacle hindering market growth is the substantial capital investment needed for deployment. The high costs involved in acquiring software licenses and upgrading IT infrastructure present a significant barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions. As a result, budgetary limitations frequently compel facilities to postpone the implementation of these tools, despite the operational efficiencies they promise.

Market Driver

A critical shortage of radiologists alongside surging imaging workloads is a primary force driving the adoption of AI in MRI. Healthcare systems are contending with a growing gap between the volume of necessary diagnostic scans and the workforce available to interpret them, necessitating automated solutions to prevent burnout and delays in diagnosis. This imbalance is underscored by workforce data; according to the Royal College of Radiologists' '2023 Clinical Radiology Workforce Census Report' released in June 2024, while the UK clinical radiology workforce increased by 6% in 2023, the demand for CT and MRI reporting rose by 11%, intensifying pressure on existing staff.

Additionally, advancements in deep learning for enhanced image reconstruction are fueling market expansion by directly improving operational efficiency and patient throughput. Modern AI algorithms allow for the creation of high-fidelity images from undersampled raw data, drastically reducing the time patients spend in scanners without sacrificing diagnostic quality. This capability was highlighted in December 2024 when GE HealthCare introduced Sonic DL for 3D, a deep learning innovation that reduces MRI scan times by up to 86%. The potential for such efficiency has attracted significant capital, as seen in February 2024 when Ezra secured $21 million to accelerate the expansion of its AI-powered MRI services.

Market Challenge

The substantial capital investment necessary for deployment significantly restricts the growth of the Global AI in MRI Market. Implementing these solutions entails high costs related to purchasing software licenses and upgrading IT infrastructure to handle data-intensive workflows. These financial requirements establish a formidable barrier to entry, particularly for smaller independent clinics and healthcare systems in developing regions that operate with limited budgets. Consequently, facilities frequently delay adoption despite the potential for enhanced operational efficiency, preventing the market from achieving its full potential volume.

Recent statistics reinforce the impact of these economic constraints on the sector. Data from the European Society of Radiology in 2024 revealed that 49.5% of surveyed members cited costs or a lack of budget as the primary barrier to implementing AI in clinical practice. This suggests that financial hurdles are a leading reason for the hesitation among radiology departments to integrate these tools. Without the necessary funding to cover initial expenses, a significant portion of the market remains unable to leverage AI capabilities, thereby directly limiting overall market expansion.

Market Trends

The integration of Generative AI for Radiology Reporting is fast becoming a crucial solution to the administrative burdens straining diagnostic workflows. Moving beyond standard image analysis, this trend employs large language models to automatically draft, customize, and structure radiological reports based on image findings and radiologist dictation, thereby cutting down documentation time and reducing radiologist fatigue. The commercial viability of this technology was strongly confirmed in January 2025, when Rad AI raised $60 million in Series C funding to hasten the adoption of its generative AI reporting platform across major healthcare systems.

Concurrently, the rise of Vendor-Neutral AI App Stores is transforming how healthcare facilities acquire and deploy artificial intelligence tools. Instead of managing fragmented contracts with individual developers, hospitals are increasingly adopting centralized orchestration platforms that offer a single interface for managing diverse algorithms from multiple vendors. This consolidation strategy was emphasized in December 2025 at RSNA 2025, where DeepHealth unveiled AI Studio, an orchestration platform integrating over 140 AI algorithms from more than 75 vendors to streamline clinical deployment and governance.

Key Market Players

  • Digital Diagnostics Inc.
  • Tempus AI, Inc.
  • Advanced Micro Devices, Inc.
  • HeartFlow, Inc.
  • Enlitic, Inc.
  • Viz.ai, Inc.
  • EchoNous Inc.
  • HeartVista Inc.
  • Exo Imaging, Inc.
  • Nano-X Imaging Ltd.

Report Scope

In this report, the Global AI in MRI Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI in MRI Market, By Clinical Application

  • Musculoskeletal
  • Colon
  • Prostate
  • Liver
  • Cardiovascular
  • Neurology
  • Lung
  • Breast
  • Others

AI in MRI Market, By Offering Type

  • Hardware
  • Software
  • Services

AI in MRI Market, By Technology

  • Deep Learning
  • Machine Learning
  • Computer Vision
  • NLP
  • Speech Recognition
  • Querying Method
  • Others

AI in MRI Market, By Deployment Type

  • On-premises
  • Cloud

AI in MRI Market, By End Use

  • Hospitals
  • Clinics
  • Research & Laboratories
  • Others

AI in MRI Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI in MRI Market.

Available Customizations:

Global AI in MRI Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI in MRI Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Clinical Application (Musculoskeletal, Colon, Prostate, Liver, Cardiovascular, Neurology, Lung, Breast, Others)
    • 5.2.2. By Offering Type (Hardware, Software, Services)
    • 5.2.3. By Technology (Deep Learning, Machine Learning, Computer Vision, NLP, Speech Recognition, Querying Method, Others)
    • 5.2.4. By Deployment Type (On-premises, Cloud)
    • 5.2.5. By End Use (Hospitals, Clinics, Research & Laboratories, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America AI in MRI Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Clinical Application
    • 6.2.2. By Offering Type
    • 6.2.3. By Technology
    • 6.2.4. By Deployment Type
    • 6.2.5. By End Use
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States AI in MRI Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Clinical Application
        • 6.3.1.2.2. By Offering Type
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Deployment Type
        • 6.3.1.2.5. By End Use
    • 6.3.2. Canada AI in MRI Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Clinical Application
        • 6.3.2.2.2. By Offering Type
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Deployment Type
        • 6.3.2.2.5. By End Use
    • 6.3.3. Mexico AI in MRI Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Clinical Application
        • 6.3.3.2.2. By Offering Type
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Deployment Type
        • 6.3.3.2.5. By End Use

7. Europe AI in MRI Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Clinical Application
    • 7.2.2. By Offering Type
    • 7.2.3. By Technology
    • 7.2.4. By Deployment Type
    • 7.2.5. By End Use
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany AI in MRI Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Clinical Application
        • 7.3.1.2.2. By Offering Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Deployment Type
        • 7.3.1.2.5. By End Use
    • 7.3.2. France AI in MRI Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Clinical Application
        • 7.3.2.2.2. By Offering Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Deployment Type
        • 7.3.2.2.5. By End Use
    • 7.3.3. United Kingdom AI in MRI Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Clinical Application
        • 7.3.3.2.2. By Offering Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Deployment Type
        • 7.3.3.2.5. By End Use
    • 7.3.4. Italy AI in MRI Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Clinical Application
        • 7.3.4.2.2. By Offering Type
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Deployment Type
        • 7.3.4.2.5. By End Use
    • 7.3.5. Spain AI in MRI Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Clinical Application
        • 7.3.5.2.2. By Offering Type
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Deployment Type
        • 7.3.5.2.5. By End Use

8. Asia Pacific AI in MRI Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Clinical Application
    • 8.2.2. By Offering Type
    • 8.2.3. By Technology
    • 8.2.4. By Deployment Type
    • 8.2.5. By End Use
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China AI in MRI Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Clinical Application
        • 8.3.1.2.2. By Offering Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Deployment Type
        • 8.3.1.2.5. By End Use
    • 8.3.2. India AI in MRI Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Clinical Application
        • 8.3.2.2.2. By Offering Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Deployment Type
        • 8.3.2.2.5. By End Use
    • 8.3.3. Japan AI in MRI Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Clinical Application
        • 8.3.3.2.2. By Offering Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Deployment Type
        • 8.3.3.2.5. By End Use
    • 8.3.4. South Korea AI in MRI Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Clinical Application
        • 8.3.4.2.2. By Offering Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Deployment Type
        • 8.3.4.2.5. By End Use
    • 8.3.5. Australia AI in MRI Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Clinical Application
        • 8.3.5.2.2. By Offering Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Deployment Type
        • 8.3.5.2.5. By End Use

9. Middle East & Africa AI in MRI Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Clinical Application
    • 9.2.2. By Offering Type
    • 9.2.3. By Technology
    • 9.2.4. By Deployment Type
    • 9.2.5. By End Use
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia AI in MRI Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Clinical Application
        • 9.3.1.2.2. By Offering Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Deployment Type
        • 9.3.1.2.5. By End Use
    • 9.3.2. UAE AI in MRI Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Clinical Application
        • 9.3.2.2.2. By Offering Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Deployment Type
        • 9.3.2.2.5. By End Use
    • 9.3.3. South Africa AI in MRI Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Clinical Application
        • 9.3.3.2.2. By Offering Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Deployment Type
        • 9.3.3.2.5. By End Use

10. South America AI in MRI Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Clinical Application
    • 10.2.2. By Offering Type
    • 10.2.3. By Technology
    • 10.2.4. By Deployment Type
    • 10.2.5. By End Use
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil AI in MRI Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Clinical Application
        • 10.3.1.2.2. By Offering Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Deployment Type
        • 10.3.1.2.5. By End Use
    • 10.3.2. Colombia AI in MRI Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Clinical Application
        • 10.3.2.2.2. By Offering Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Deployment Type
        • 10.3.2.2.5. By End Use
    • 10.3.3. Argentina AI in MRI Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Clinical Application
        • 10.3.3.2.2. By Offering Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Deployment Type
        • 10.3.3.2.5. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global AI in MRI Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Digital Diagnostics Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Tempus AI, Inc.
  • 15.3. Advanced Micro Devices, Inc.
  • 15.4. HeartFlow, Inc.
  • 15.5. Enlitic, Inc.
  • 15.6. Viz.ai, Inc.
  • 15.7. EchoNous Inc.
  • 15.8. HeartVista Inc.
  • 15.9. Exo Imaging, Inc.
  • 15.10. Nano-X Imaging Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer